Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olympus (OLYMY)
OTHER OTC:OLYMY
Holding OLYMY?
Track your performance easily
OLYMY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.56 - $19.79
Previous CloseN/A
Volume14.55K
Average Volume (3M)145.62K
Market Cap
$17.23B
Enterprise Value$21.75B
Total Cash (Recent Filing)$201.08B
Total Debt (Recent Filing)$217.19B
Price to Earnings (P/E)34.5
Beta0.83
Next Earnings
Feb 07, 2025EPS Estimate
0.23Last Dividend Ex-Date
Mar 30, 2023Dividend Yield0.78%
Share Statistics
EPS (TTM)0.43
Shares Outstanding1,177,700,200
10 Day Avg. Volume271,195
30 Day Avg. Volume145,618
Standard Deviation0.08
R-Squared0.23
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue0.02
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Olympus News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
OLYMY FAQ
What was Olympus’s price range in the past 12 months?
Olympus lowest stock price was $13.56 and its highest was $19.79 in the past 12 months.
What is Olympus’s market cap?
Olympus’s market cap is $17.23B.
When is Olympus’s upcoming earnings report date?
Olympus’s upcoming earnings report date is Feb 07, 2025 which is in 6 days.
How were Olympus’s earnings last quarter?
Olympus released its earnings results on Nov 08, 2024. The company reported $0.193 earnings per share for the quarter, missing the consensus estimate of $0.212 by -$0.019.
Is Olympus overvalued?
According to Wall Street analysts Olympus’s price is currently Overvalued.
Does Olympus pay dividends?
Olympus pays a Annually dividend of $0.12 which represents an annual dividend yield of 0.78%. See more information on Olympus dividends here
What is Olympus’s EPS estimate?
Olympus’s EPS estimate is 0.23.
How many shares outstanding does Olympus have?
Olympus has 1,177,700,200 shares outstanding.
What happened to Olympus’s price movement after its last earnings report?
Olympus reported an EPS of $0.193 in its last earnings report, missing expectations of $0.212. Following the earnings report the stock price went down -1.021%.
Which hedge fund is a major shareholder of Olympus?
Currently, no hedge funds are holding shares in OLYMY
---
Olympus Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.27%
12-Months-Change
Fundamentals
Return on Equity
11.19%
Trailing 12-Months
Asset Growth
-11.87%
Trailing 12-Months
Company Description
Olympus
Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
---
OLYMY Company Deck
---
OLYMY Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view of strong revenue growth and progress in technological advancements, such as AI endoscopy devices and the Elevate program. However, challenges remain, particularly in the Chinese market and leadership stability following the CEO scandal.Read More>---
Technical Analysis
Becton Dickinson
―
Boston Scientific
―
Intuitive Surgical
―
Stryker
―
Zimmer Biomet Holdings
―
---